|
業務類別
|
Biotechnology |
|
業務概覽
|
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals. |
| 公司地址
| 400 Alexander Park Drive, Suite 301, Princeton, NJ, USA, 08540 |
| 電話號碼
| +1 609 642-6670 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.pmvpharma.com |
| 員工數量
| 54 |
| Mr. Robert Ticktin |
General Counsel and Chief Operating Officer |
美元 450.00K |
22/04/2026 |
| Mr. Michael Carulli |
Chief Financial Officer and Principal Accounting Officer |
-- |
22/04/2026 |
| Dr. Deepika Jalota, Pharm.D. |
Chief Development Officer |
美元 478.43K |
22/04/2026 |
| Dr. David H. Mack, PhD |
President, Chief Executive Officer and Director |
美元 628.46K |
22/04/2026 |
|
|
| Dr. Charles M. Baum, M.D.,PhD |
Independent Director |
22/04/2026 |
| Ms. Laurie D. Stelzer, M.B.A. |
Independent Director |
22/04/2026 |
| Dr. David H. Mack, PhD |
President, Chief Executive Officer and Director |
22/04/2026 |
| Dr. Carol G. Gallagher,Pharm.D. |
Independent Director |
22/04/2026 |
| Dr. Richard Heyman, PhD |
Chairman of the Board |
22/04/2026 |
| Dr. Arnold J. Levine,PhD |
Independent Director |
22/04/2026 |
| Ms. Kirsten Flowers |
Independent Director |
22/04/2026 |
|
|
|
|
